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 Abstract 
  Background:  Docosahexaenoic acid (DHA) is one of the n–3 polyunsaturated fatty acids and an 
important component of cell membrane phospholipids (PL). Nephrotoxic serum (NTS) nephritis 
was a worldwide model of the Goodpasture syndrome. We investigated the effects of tridoco-
sahexaenoyl-glycerol (DHA-TG) emulsion on proteinuria in rats with NTS nephritis.   Methods:  
Sixteen male Wistar rats weighing approximately 200 g were used. Twelve rats were treated 
with NTS via the tail vein and divided into 3 groups (groups A, B, and C). Another 4 rats treated 
with saline served as controls (group D). DHA-TG and soybean oil emulsions were intraperitone-
ally administered to the rats in groups A and B, respectively, 24 h prior to NTS injection, and 0, 
1, 2, 3, 4, and 5 days after the injection. Saline was administered to the rats in groups C and D in 
the same manner. All rats were sacrificed on day 6 to obtain plasma and kidney samples. Analy-
ses of urinary protein levels and fatty acid composition of plasma and kidney as well as histo-
logical examination of the kidneys were performed.   Results:   Urinary protein levels in group A 
were significantly lower than those in group C (35.0   8   13.3 vs. 79.2   8   11.8 mg/day on day 5, 
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means   8   SE, p   !   0.05). DHA levels in the PL fraction of the kidneys in group A were significant-
ly increased compared with those in groups B and C.   Conclusions:   These results suggest that 
the DHA-TG emulsion may have beneficial effects on NTS nephritis in the rat. 
  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Docosahexaenoic acid (DHA) is one of the n–3 polyunsaturated fatty acids. It has 22 car-
bon atoms and 6 double bonds, and is an important component of cell membrane phospho-
lipids (PL)   [1]  . DHA is found in the brain, nervous system, heart, and sperm of land animals, 
and metabolizes to some chemical mediators. In addition, it modifies the production of pros-
taglandins and leukotrienes  [2] . Consequently, DHA might have anti-inflammatory and anti-
atherosclerotic effects. 
  Nephrotoxic serum (NTS) nephritis is a worldwide model of the Goodpasture syndrome. 
This model was first reported by Masugi   [3]   in 1933. NTS nephritis includes heterologous 
and autologous phases. The heterologous phase consists of activation of complements, glo-
merular endothelial injury, platelet aggregation, and migration of polymorphonuclear leu-
kocytes (PMNL)   [3]  . The autologous phase consists of formation of an immune complex, 
progression of glomerular injury, proliferation of endothelial and mesangial cells, and for-
mation of crescents   [3]  . We have previously reported that DHA administration decreased 
leukotriene B  4  production by PMNL in rabbits  [4] . Consequently, we hypothesized that DHA 
administration might suppress proteinuria in rats with NTS nephritis by preventing a reac-
tion in the heterologous phase. In the present study, we injected tridocosahexaenoyl-glycer-
ol (DHA-TG) emulsion into rats with NTS nephritis and investigated their urinary protein 
levels and fatty acid composition of plasma and kidneys.
  M e t h o d s  
 Experimental  Animals 
 Male Wistar rats weighing approximately 200 g were purchased from Clea Japan (Tokyo, 
Japan), maintained in our animal facility, and allowed free access to standard rat chow and 
tap water throughout the experiment. This study was conducted in accordance with the 
Guidelines for Animal Experiments of the Hirosaki University. 
  Preparation  of  NTS 
  Rat glomerular basement membranes obtained from perfused renal cortices were di-
gested with trypsin (Sigma, St. Louis, Mo., USA) for 3 h at 37    °    C. After heating the digest at 
60    °    C for 30 min, the mixture was centrifuged at 76,000   g   for 1 h and the supernatant was 
lyophilized. To produce NTS, 2 white rabbits were subcutaneously injected with the lyophi-
lized sample emulsified in complete Freund’s adjuvant. Subsequent injections were admin-
istered 2, 4, and 6 weeks after the initial immunization. The rabbits were bled in the 7th week 
and sera were collected. Sera exhibiting nephrotoxic potency (demonstrated by proteinuria 
induction in rats after the intravenous injection of 0.2 ml antiserum) were pooled. The pooled 
antiserum was heat inactivated at 56    °    C for 30 min and stored at –20    °    C until use.
  E x p e r i m e n t a l   D e s i g n  
  Twelve rats were treated with NTS via the tail vein and divided into 3 groups (groups 
A, B, and C). Another 4 rats treated with saline served as controls (group D). DHA-TG and 141
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soybean oil emulsions (10 ml/kg) were intraperitoneally administered to the rats in groups 
A and B, respectively, 24 h prior to NTS injection and 0, 1, 2, 3, 4, and 5 days after the injec-
tion. Saline (10 ml/kg) was administered to the rats in groups C and D in the same manner. 
Urine samples were obtained individually during the experiment. All rats were sacrificed 
on day 6 to obtain plasma and kidney samples. Urinary protein levels and fatty acid com-
position of plasma and kidneys were assessed, and the kidneys were examined histologi-
cally (  fig. 1  ).
    Preparation of DHA-TG Emulsion 
 DHA-TG (66% pure) was donated from Kentech (Toyama, Japan). DHA-TG was fortified 
with 0.2%     -tocopherol and emulsified with egg yolk lecithin   [5]  . One hundred milliliters of 
DHA-TG emulsion contained 10 g DHA-TG, 1.2 g egg yolk lecithin as an emulsifier, and 2.5% 
glycerol for osmotic pressure. The fatty acid composition of the DHA-TG emulsion was as 
follows: 6.5% palmitic acid (16:     0), 3.4% stearic acid (18:     0), 5.5% oleic acid (18:    1n–9),  1.6% 
linolenic acid (LA; 18:    2n–6), 0.2%   -LA (18:   3n–3), 2.7% arachidonic acid (AA; 20:    4n-6), 6.5% 
eicosapentaenoic acid (EPA; 20:    5n–3), and 65.7% DHA (22:    6n–3). The fatty acid composition 
of the soybean oil emulsion was as follows: 13.6% palmitic acid (16:     0), 5.0% stearic acid (18:   
  0), 19.3% oleic acid (18:     1n–9), 50.1% LA (18:     2n–6), 9.8%    -LA  (18:    3n–3), 0.4% AA (20:    4n–6), 
0.0% EPA (20:     5n–3), and 0.5% DHA (22:    6n–3). 
    Biochemical Analysis of Urine and Plasma 
  Urinary protein levels as well as total protein, creatinine, and total cholesterol levels in 
plasma were all analyzed enzymatically.
  Histological  Examination 
  Right kidneys were obtained for light- and immunofluorescence-microscopic examina-
tions. Each specimen was fixed in 10% buffered formalin and embedded in paraffin for light-
microscopic examination. Sections (2-  m thick) were stained with periodic acid-Schiff. Fro-
zen sections (5-    m thick) were cut using a cryostat and stained with fluorescein isothiocya-
nate (FITC)-conjugated anti-rat IgG, IgA, IgM (Bethyl Laboratories, Montgomery, Tex., 
USA), FITC-conjugated anti-rat C  3   (MP Biomedicals, Aurora, Ohio, USA), and FITC-con-
jugated anti-mouse IgG (Wako, Osaka, Japan).
  Fig. 1.   Experimental design. The 
circles indicate administration 
of the same drug or reagent as 
used on day 0.  142
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    Fatty Acid Analysis of Plasma and Kidney 
 Left kidneys were obtained for analyzing fatty acid composition. Total lipids in a plasma 
or kidney homogenate in PBS were extracted according to the method of Bligh and Dyer  [6] ; 
PL, triglyceride (TG), and free fatty acid (FFA) were separated by thin-layer chromatography; 
after transmethylation with HCl-methanol, the fatty acid composition was analyzed by gas 
chromatography (GC-14A; Shimadzu, Kyoto, Japan) with a capillary column (length, 30 m; 
internal diameter, 0.25 mm; film 0.25     m; J&M Scientific, Folsom, Calif., USA); column 
temperature was kept at 170    °    C for the 1st min, increased to 220    °    C at a rate of 4    °   C/min,  and 
kept at this temperature for 22 min; the entire system was controlled with gas-chromato-
graphic software (CLASS-GC10 1.3; Shimadzu). 
  Statistical  Analysis 
  Data were expressed as means   8   SD or SE (  fig. 1  ). Statistical analysis was performed by 
Scheffe’s method. p   !   0.05 was considered significant.
  R e s u l t s  
  Changes in urinary protein levels in the 4 groups are shown in   figure 2  . Urinary protein 
levels in group A were significantly lower than those in group C on days 1, 2, and 5 after the 
injection of emulsion (22.5   8   8.7 vs. 70.7   8   21.5 mg/day on day 1, 34.0   8   14.9 vs. 135.2   8  
56.1 mg/day on day 2, 35.0   8   13.3 vs. 79.2   8   11.8 mg/day on day 5, means   8   SE, p   !   0.05). 
    Changes in the fatty acid composition of the PL fraction of the kidneys in the 4 groups 
are shown in   table 1  . In group A, AA levels were significantly lower than those in groups B, 
C, and D, LA levels were significantly higher than those in group C, and EPA and DHA lev-
els were significantly higher than those in groups B, C, and D. 
    Changes in the fatty acid composition of the plasma PL fraction in the 4 groups are 
shown in   table 1  . AA levels in group A were significantly lower than those in groups B and 
D. EPA levels in group A were significantly higher than those in groups B, C, and D. DHA 
levels in the plasma PL fraction were not significantly different among the 4 groups. Chang-
es in the fatty acid composition of the plasma TG fraction in the 4 groups are shown in   ta-
ble 2  . LA levels in group A were significantly lower than those in group C. EPA and DHA 
levels in group A were significantly higher than those in groups B, C, and D. Changes in the 
fatty acid composition of the plasma FFA fraction in the 4 groups are shown in   table 3  . In 
group A, oleic acid and LA levels were significantly lower than those in group C, AA levels 
  Fig. 2.   Urinary protein levels in the 4 groups. 
Twelve rats were treated with NTS via the tail vein 
and divided into 3 groups (groups A, B, and C). 
Another 4 rats treated with saline served as con-
trols (group D). DHA-TG (10 ml/kg) and soybean 
oil (10 ml/kg) emulsions were intraperitoneally ad-
ministered to the rats in groups A and B, respec-
tively, 24 h prior to NTS injection and 0, 1, 2, 3, 4, 
and 5 days after the injection. The same dose of 
saline was administered to the rats in groups C and 
D in the same manner. Urine samples were ob-
tained individually during the experiment (days 1, 
2, 4, and 5). Means   8   SE,   *  p   !   0.01 vs. group D.  143
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were significantly lower than those in groups B and C, and EPA levels were significantly 
higher than those in groups B, C, and D. DHA levels in the plasma FFA fraction were not 
significantly different among the 4 groups.
    Light microscopy showed that mesangial proliferative glomerulonephritis was induced 
by NTS administration in groups A, B, and C, but not in group D. No significant differences 
were observed in histological changes in the kidneys among groups A, B, and C (  fig. 3  ). In 
the immunofluorescence microscopic study, no difference was observed in the staining in-
tensity of bound rat C3, rat IgG and mouse IgG in the glomeruli among groups A, B, and C. 
No staining was observed in the glomeruli of group D.
    Changes in total protein, total cholesterol, and creatinine levels in the plasma in the 4 
groups are shown in   table 4  . Total plasma cholesterol levels in group A were significantly 
lower than those in groups B and C. Total protein and creatinine levels in the plasma were 
not significantly different among the 4 groups.
Table 1.   Changes in the fatty acid composition (mol%) of the PL fraction in the kidney and in plasma in 
the 4 groups
N  TS nephritis Group D
gr  oup A group B group C
Changes in the kidney
Oleic acid 06.9580.16 07.2280.44 06.5180.61 07.1880.33
LA 15.2780.22 14.6880.61 14.1980.71* 15.0280.22
AA 23.8680.59 25.4280.58* 26.6280.18** 26.1581.00**
EPA 01.5580.08 00.7880.07** 00.8280.13** 00.8280.04**
DHA 03.2780.02 02.5980.28** 02.6780.20** 02.4780.04**
Changes in plasma
Oleic acid 04.0580.21 03.7280.30 03.8180.13 03.7180.11
LA 23.3080.74 22.5180.83 23.0481.29 24.2980.46
AA 13.2480.75 15.7881.13** 13.2580.33 15.1580.67*
EPA 00.9580.14 00.5380.05** 00.3880.05** 00.5280.04**
DHA 04.8580.23 04.7880.39 05.3680.98 04.0980.34
DHA  emulsion (10 ml/kg; group A), 10 ml/kg of soybean oil emulsion (group B), and 10 ml/kg of saline 
(group C) were intraperitoneally administered to rats 24 h prior to NTS injection, and 0, 1, 2, 3, 4, and 5 
days after the injection. Group D was the control group (no nephritis). All rats were sacrificed on day 6 to 
obtain plasma and kidney samples. Means 8 SD. * p < 0.05, ** p < 0.01, vs. group A.
Table 2.   Changes in the fatty acid composition (mol%) of the TG fraction in plasma in the 4 groups
N  TS nephritis Group D
gr  oup A group B group C
Oleic acid 19.1680.55 20.2781.77 20.6281.40 20.5180.60
LA 32.7182.01 34.5082.46 36.9681.60* 35.8280.40
AA 01.7180.30 02.1380.36 02.0680.01 01.8780.35
EPA 02.8880.75 01.6480.31* 01.5780.30* 01.7680.54*
DHA 10.5881.45 06.1580.83** 05.2080.89** 06.4780.19**
For further information, see legend to table 1.144
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  Discussion 
 In the present study, we first demonstrated that administration of the DHA-TG emulsion 
suppressed proteinuria in rats with NTS nephritis. There are several possible mechanisms of 
reduction of proteinuria by DHA-TG emulsion. Increased DHA levels in the PL fraction of 
PMNL suppressed PMNL migration by reducing leukotriene B  4   production   [4]  . Novel me-
diators, such as protectin converted from DHA   [7]  , suppressed the inflammatory reaction in 
the heterologous phase due to NTS injection. Administration of the DHA-TG emulsion might 
ameliorate proteinuria in rats with NTS nephritis by inhibiting PMNL migration. 
  As shown in  table 1 , DHA and EPA levels increased after DHA-TG injection. This might 
have occurred because the DHA-TG emulsion contains 6.5% EPA (see Methods) and the in-
jected emulsion might have retroconverted to EPA in the kidneys and/or other organs. 
Changes in the fatty acid composition of plasma are shown in  tables 2  and  3 . Although DHA 
levels in the plasma TG fraction were significantly increased after DHA-TG injection, DHA 
Table 3.   Changes in the fatty acid composition (mol%) of the FFA fraction in plasma in the 4 groups
N  TS nephritis Group D
gr  oup A group B group C
Oleic acid 17.1381.75 16.0781.18 20.0780.96* 17.9780.79
LA 28.8081.19 27.4182.23 33.1580.28** 29.5580.55
AA 03.4380.44 05.2980.75** 04.7680.37* 04.0480.72
EPA 01.0580.25 00.7480.10* 00.6980.11* 00.6880.07*
DHA 04.1181.39 03.2780.41 04.0780.25 02.8680.25
DHA   emulsion (10 ml/kg; group A), 10 ml/kg of soybean oil emulsion (group B), and 10 ml/kg of sa-
line (group C) were intraperitoneally administered to rats 24 h prior to NTS injection, and 0, 1, 2, 3, 4, and 
5 days after the injection. Group D was the control group (no nephritis). All rats were sacrificed on day 6 
to obtain plasma and kidney samples. Means 8 SD. * p < 0.05, ** p < 0.01, vs. group A.
  Fig. 3.   Representative light-microscopic findings on day 6 in each group. Mesangial proliferative glomer-
ulonephritis was observed in groups A, B and C. Original magnification   ! 400.   145
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levels in the plasma PL and FFA fractions did not increase after injection. This might be due 
to the fact that the emulsion used in the present study was a TG form of DHA. Consequent-
ly, DHA levels in the plasma TG fraction alone might have increased after injecting the emul-
sion compared to those in the PL or FFA fraction.
  In the present study, histological examination revealed no significant differences among 
groups A, B, and C, possibly because the NTS nephritis model might not be able to distin-
guish the differences in mesangial proliferative glomerulonephritis. Total plasma cholester-
ol levels in group A were lower than those in groups B and C (  table 4  ). This result suggests 
that DHA might accelerate the metabolism of lipoproteins, such as chylomicrons or very-
low-density cholesterol. Kielar et al.   [8]   demonstrated that DHA ameliorated murine isch-
emic acute renal failure. Halade et al.   [9]   reported that DHA attenuated kidney disease and 
prolonged the life span of autoimmune lupus-prone mice. However, reports on the effects of 
DHA-TG on proteinuria in NTS nephritis have not been published to date. 
    In conclusion, we demonstrated that the administration of the DHA-TG emulsion de-
creased proteinuria in rats with NTS nephritis in this preliminary study. These beneficial 
effects might be due to the suppressive effects of DHA on PMNL.
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Table 4.   Total protein, total cholesterol, and creatinine levels (mg/dl) in plasma in the 4 groups
N  TS nephritis Group D
grou  p A group B group C
Total protein 05.980.3 006.080.1 006.280.1 05.980.1
Total cholesterol 73.3816.7 107.5818.9* 103.0810.4* 72.580.7
Creatinine 0.2480.01 00.2380.02 00.2380.01 0.2380.01
DHA  emulsion (10 ml/kg; group A), 10 ml/kg of soybean oil emulsion (group B), and 10 ml/kg of saline 
(group C) were intraperitoneally administered to rats 24 h prior to NTS injection, and 0, 1, 2, 3, 4, and 5 
days after the injection. Group D was the control group (no nephritis). All rats were sacrificed on day 6 to 
obtain plasma and kidney samples. Total protein, total cholesterol, and creatinine levels in plasma were 
analyzed enzymatically. Means 8 SD. * p < 0.05 vs. group A. 
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